… Most fibroids appear de novo and continue to grow until menopause if untreated. Historically…
for management of symptomatic fibroids. It results in a reduction in fibroid size of 40% to 60%…

… Fifty-nine women with symptomatic uterine fibroids; G (n = 31) vs. E … gelfoam pledgets alone
or gelfoam plus embospheres (500–700 μm). Baseline, 3, 6, and 12 month dominant fibroid …

… studies of successful fibroid embolization using Gelfoam, our … Gelfoam pledgets (used in
this study) are able to be directly … age to treat symptomatic myoma and postpone pregnancy …

… with Gelfoam (Phannacia & Upjohn, Kalamazoo, MI) pled gets … to infarct the patients' fibroids
without causing any symptoms of … in the case of the elective treatment of fibroid disease. …

… myoma size reduction, whether the occluding agent was polyvinyl alcohol, polyvinyl alcohol
plus gelfoam, or gelfoam, … tion include those with symptomatic uterine leiomyomas, who no …

… Seventeen patients had concomitant fibroids, all of which … [22] observed that gelfoam may
be used to treat symptomatic … proximal gelfoam pledget embolization and distal gelfoam slurry …

… myoma size reduction whether occluding agents was polyvinyl alcohol, polyvinyl alcohol plus
gelfoam, and gelfoam, … Uterine artery embolization for symptomatic uterine myomas. Fertil …

… % but re-growth of fibroid may however occur. The rate … fibroid, UAE is typically performed
in both uterine arteries. Different embolic agents are used such as polyvinyl alcohol, gelfoam …

… by gelfoam pledgets; the results are presented here. … for the fibroids by embolizing the
bilateral uterine arteries through a catheter. It is safe, minimally invasive and effective for symptom …

… effectiveness and durability of gelfoam in treating women with symptomatic uterine myomas
… a pregnancy to term [I] Our results with gelfoam as the embolic agent in UFE suggest that its …